SCHEMBL10900554

SCHEMBL10900554

CC(C)OC(=O)CC(=N)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
TSHR P16473 3/20 0.39
MAPT P10636 3/20 0.34
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALDH1A1 P00352 2/20 0.33
AGTR1 P30556 1/20 0.33
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7273082 0.98 LMNA (0.39) LMNATSHRMAPTF2F10
SCHEMBL2792579 0.81 LMNA (0.43) LMNATSHRMAPTCHRM2CHRM4
SCHEMBL229792 0.80 TSHR (0.50) LMNATSHRMAPTCYP2D6ALDH1A1
SCHEMBL11669499 0.78 LMNA (0.39) LMNAALDH1A1
SCHEMBL28727541 0.78 LMNA (0.48) LMNATSHRMAPTCYP2D6ALDH1A1
SCHEMBL28875912 0.78 LMNA (0.48) LMNATSHRMAPTCYP2D6ALDH1A1
SCHEMBL28315849 0.78 LMNA (0.48) LMNATSHRMAPTCYP2D6ALDH1A1
SCHEMBL18152012 0.78 LMNA (0.48) LMNATSHRMAPTCYP2D6ALDH1A1
Hydrochloric Acid SCHEMBL8805713 0.77 LMNA (0.41) LMNATSHRMAPTCYP2D6ALDH1A1
SCHEMBL14087042 0.77 NLRP3 (0.40) LMNATSHRMAPTF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3951990-A CORONARY AGENTS, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DT) 1976-04-20 US claimed
US-8084643-B2 Nitrogen-containing esters of the secondary alcohol group of florfenicol and of its analogs,including salts; veterinary medicine; nonhydrolyzing as needed to maintain the prodrug in aqueous solution in the subjects system until appropriate; cattle drinking water; bovine respiratory disease INTERVET INC. (US) 2011-12-27 US disclosed
US-8044230-B2 Hydrolytic stability needed to maintain the prodrug in solution in the subject's system until appropriate conditions exist when the prodrug can hydrolyze, releasing the active compound INTERVET INC. (US) 2011-10-25 US disclosed
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-08-07 US disclosed
US-20080153906-A1 Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System INTERVET INC. 2008-06-26 US disclosed
US-20080146640-A1 Water-Soluble Prodrugs of Chloramphenicol, Thiamphenicol, and Analogs Thereof SCHERING-PLOUGH LTD. (CH) 2008-06-19 US disclosed
US-4622332-A Asymmetric diesters of Hantzsch dihydropyridines with hypotensive activity BAYER AKTIENGESELLSCHAFT (DE) 1986-11-11 US disclosed
US-4049662-A HYPOTENSIVE AGENTS, VASODILATORS BAYER AKTIENGESELLSCHAFT (DT) 1977-09-20 US disclosed
US-4022898-A ANTIHYPERTENSIVE AGENTS, VASODILATORS BAYER AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed
US-4016277-A ANTIHYPERTENSIVE AGENTS AND CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1977-04-05 US disclosed
US-3971791-A VASODILATION, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US disclosed
US-3959474-A 2,6-Diamino-1,4-dihydropyridine-3,5-dicarboxylic acid esters used as coronary vessel dilators and anti-hypertensive agents BAYER AKTIENGESELLSCHAFT (DT) 1976-05-25 US disclosed
US-3957998-A ADMINISTERING BAYER AKTIENGESELLSCHAFT (DT) 1976-05-18 US disclosed
US-3951990-A CORONARY AGENTS, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DT) 1976-04-20 US disclosed
US-3951992-A CORONARY, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DT) 1976-04-20 US disclosed
US-3951991-A CORONARY AGENTS, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DT) 1976-04-20 US disclosed
US-3950336-A HYPOTENSIVE AGENTS, CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed
US-3946026-A HYPOTENSIVE AGENTS, CORONARY VESSEL DILATORS BAYER AKTIENGESELLSCHAFT (DT) 1976-03-23 US disclosed
US-3939171-A HYPOTENSIVE, VASODILATION BAYER AKTIENGESELLSCHAFT (DT) 1976-02-17 US disclosed
US-3935223-A 2-Amino-1,4-dihydropyridine derivatives BAYER AKTIENGESELLSCHAFT (DT) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153906-A1 Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System BPHL, CYP4B1, CYP4A22 LMNA 614/4885TSHR 2907/4885MAPT 1057/4885
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs PFAS, ADH5, SI LMNA 2524/4885TSHR 3559/4885MAPT 2357/4885
US-20080146640-A1 Water-Soluble Prodrugs of Chloramphenicol, Thiamphenicol, and Analogs Thereof TREH, ADH5, CES2 LMNA 3313/4885TSHR 1911/4885MAPT 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.